Abstract
Introduction
The classical paradigm says that for an arrhythmia to be induced both a substrate and a trigger is needed. The human ether-a-go-go related gene (hERG) encodes the pore forming protein of the rapidly activated delayed rectifier K + current (I Kr ), one of the most important currents that contributes to the repolarisation of the human heart. Reduction of this current either by a mutation in the gene or by a blockade of the channel by drugs produce congenital and acquired Long QT Syndrome (LQTS) respectively, creating a substrate that increases the risk of ventricular fibrillation [1] . The clinical observation showed that, in patients with LQTS, arrhythmias are typically triggered during physical or emotional stress, suggesting a link between sympathetic stimulation and arrhythmias. Sympathetic stimulation exerts different proarrhythmic effects, such as an increase of I f or L-type Ca 2+ currents and a reduction of hERG potassium channel activity [2, 3] . In fact, activation of both β-and α-adrenoceptors (-ARs) regulate I Kr .
β-AR stimulation has been proposed to regulate the Kv4.3 and hERG channels in cardiac myocytes [4] and heterologous systems inducing either an increase or a decrease of the hERG current. The proposed regulatory mechanisms of hERG included direct interaction of cAMP with the CNBD (cyclic nucleotide binding domain) of the channel, PKA-dependent phosphorylation and dynamic interaction with the 14-3-3 protein [5] [6] [7] [8] . However, it was later demonstrated that cyclic nucleotides do not directly modulate hERG channels [9] , and hERG-14-3-3 interaction has not been demonstrated in native cells. In fact, only an increase of I Kr via the activation of PKA has been demonstrated in native ventricular cells [10] . Regarding α1 adrenoceptors, although α1-AR activation also reduces native I Kr and I hERG in cardiac myocytes and in heterologous expression systems respectively, the specific mechanism remains elusive.
In 1999 it was reported for the first time a reduction in the I hERG upon α1-AR activation, but the G protein involved was not determined [11] . Later works proposed that phosphatidylinositol 4,5-bisphosphate (PIP 2 ) consumption by PLC mediated hydrolysis might cause such reduction [12] , probably involving a direct interaction between PIP2 and the C terminus of the channel [13] . However, the PIP 2 -dependent regulation of hERG channel has been questioned since and is currently believed it is not essential for normal channel function [14, 15] .
Simultaneously, other works proposed that the reduction of the I hERG upon α1-AR stimulation was due to the phosphorylation of the hERG channel by PKA and PKC [16] [17] [18] . However, when mutation experiments in Xenopus oocytes showed that deletion of most of the consensus phosphorylation sites did not prevent the effect, authors suggested that hERG channels were modulated by PKA and PKC independently of direct phosphorylation [19] . It is important to note that not all the putative phosphorylation sites were mutated in that work and, therefore, the direct channel phosphorylation cannot be totally excluded.
In this work we aimed to investigate the molecular mechanism by which sympathetic activation of α1-AR regulates ventricular I Kr . Thus, we analyzed the effect of α1-AR stimulation on hERG channel in Human Embryonic Kidney (HEK293) cells and on I Kr in feline cardiac myocytes.
Isolation of feline cardiomyocytes
Animal studies have been approved by the Ethics Committee for the Humane Use of Laboratory Animals of the University of Colima (México) and the experiments were conducted following the ethical standards laid down in the Declaration of Helsinki and its later amendments.
Single right ventricular myocytes were obtained from adult cats as described previously [21] . Hearts were mounted on a Langendorff apparatus and perfused for 5 min with normal Tyrode's solution, and then switched to a nominally calcium-free solution for an additional 5 min. Thereafter, the hearts were perfused for 30 min with a zero-calcium solution containing 1 mg/ml type I collagenase (Sigma-Aldrich, St. Louis, MO) and 0.05 mg/ml protease XIV (Sigma-Aldrich). The enzymes were washed out by perfusion with a highpotassium, low chloride saline (KB medium) for 5 min [22] . The free wall of the right ventricle was dissected away from the rest of the heart, placed in beakers, and cut into small pieces. Single cells were maintained in a high-potassium, low chloride solution at 4°C for 2 h before use in electrophysiological experiments.
Tyrode's solution had the following composition (in mM): 125 NaCl, 24 NaHCO 3 , 0.42 NaH 2 PO 4 , 5. Following the patch rupture, whole cell membrane capacitances were measured from integration of the capacitive transients elicited by voltage steps from -50 to -60 mV, which did not activate any time dependent membrane current. Series resistances were compensated 80% in order to minimize voltage errors and were checked regularly throughout the experiment to ensure that there were no variations with time. The voltage-clamp experimental protocols were controlled with the "Clampex" program of the "pClamp" software (Molecular Devices). HEK293 cells were perfused with the external solution containing (in mM): 136 NaCl, 4 KCl, 1 MgCl2, 10 HEPES-Na, 1.8 CaCl 2 and 10 glucose, pH 7.4 with NaOH. For cardiac myocytes the bathing solution was (in mM): 140 NaCl, 5.4 KCl, 0.1 CaCl 2 , 0.4 CoCl 2 , 1.0 MgCl 2 , 10 HEPES and 11 glucose, pH adjusted to 7.4 with NaOH. HMR-1556 1 µM was added to block I Ks . For HEK-hERG cells terfenadine 1 µM was added at the end of the experiment and the remaining endogenous current was subtracted.
To elicit I hERG and I Kr we applied depolarizing pulses from -40 to +70 in 10 mV increments for 2 s every 30 seconds from a holding potential of -80 mV. These pulses were followed by a pulse at -40 mV for 5 s to measure tail current. I-V curves were obtained by measuring the current at the end of the test pulses, normalized to cell capacitance and expressed as pA/pF. The peak of the tail current was normalized to the Cellular Physiology and Biochemistry maximum current and curves were fitted to Boltzmann relation I=1/ [1 + e(V h -V)/k], were I is the amplitude of the tail current, V h is a half-maximal activation, V is the applied membrane voltage and k is the slope factor. Clampfit 10.2 software was used for the analysis of currents. The deactivation kinetics were calculated by fitting the decay of tail currents to a monoexponential function.
Drugs
Phenylephrine (PE), propranolol and neomycin were from Sigma-Aldrich. GP antagonist 2A (GPant2A); and bisindolylmaleimide 1 (BIS-1) were from Calbiochem. 1-phosphatidyl-1D-myo-inositol-3,4-bisphosphate (diC8-PIP 2 ) was from Echelon Biosciences. Anti-PIP 2 was from Santa Cruz Biotechnology. HMR-1556 was from Tocris.
Statistical analysis
Values are presented as mean ± SEM. Student's t-test for paired data was used to compare the difference between two means. p<0.05 was considered significant.
Results

Phenylephrine reduces I hERG in HEK293 cells
Cell lysates were immunoblotted to confirm the membrane expression of the α1A-adrenergic receptor and the hERG channel. The adrenoceptor, as well as the two bands, mature glycosilated and inmature non-glycosilated, characteristic of the hERG channel proteins were detected only in transfected HEK-hERG cells (Fig. 1A) .
Transfection was functional and cells responded to receptor stimulation with phenylephrine (PE). Thus, hERG channel current was recorded before and five minutes after 20 µM PE administration and a reduction on both activated I hERG and tail current was observed (Fig. 1B) . The current-voltage (I-V) relationship normalized to cell capacitance of the I hERG at the end of the 2 seconds pulse in control and PE stimulation shows current inhibition in a wide voltage range: between -10 to +30 mV. Because of the channel rectification properties, as the voltage increased the contribution of hERG channels to the total current become smaller and therefore the effect of PE was lower (Fig. 1C) . Analysis of hERG tail currents showed that PE accelerates the current deactivation. When fitted to a monoexponential function, τ deact was accelerated from 1331 ± 74 to 639 ± 44 ms (n = 37 paired cells, p<0.0001). The voltage dependence of hERG activation was calculated from plots of tail current amplitudes (normalized to the peak current) versus voltage. PE administration caused a 14 mV positive shift in the activation half voltage (V h ), from 10.9 ± 1.9 to 25.1 ± 2.1 mV (n = 37 paired cells; p < 0.001), and this effect was concentration-dependent, with an EC 50 = 12 µM (Fig. 1D, E) . PE concentrations higher than 40 µM PE fully eliminated the I hERG .
α1-AR stimulation shifts hERG channel activation V h
Since hERG channel has a great susceptibility to be blocked by many different drugs, we first tested whether the effects of PE on I hERG were due to α1-AR stimulation or to a blockade of the channel. Thus, when 20 µM PE was added to hERG expressing HEK cells not transfected with the receptor, we still observed a faster tail current deactivation (1420±98 vs 998±85 ms; n = 18 paired cells, p<0.0001), suggesting a direct open channel blockade of the channel by PE. Conversely, the activation half voltage was not affected by phenylephrine in the absence of the receptor (Fig. 2) . This result demonstrates that the positive shift in the hERG activation half voltage requires α1-AR stimulation. In conclusion, the mechanism responsible for the I hERG reduction after the α1-AR activation is the positive displacement of the activation half voltage because, at a given membrane potential, the current amplitude is expected to be reduced.
Neither minK nor MIRP1 modulate the α1-AR regulation of hERG channels
Although the real hERG partners in native systems is a matter of debate, in heterologous expression systems hERG channels can interact with the accessory proteins minK and MIRP1 [24] . We wondered whether these proteins could affect the α1-AR-induced I hERG reduction, so we transfected HEK-hERG cells with the receptor plus one of the accessory subunits and tested the effects of PE. Membrane expression of minK and MIRP1 was confirmed by Western blot (Fig. 2B) .
Current recordings showed that 20 µM PE shifted the I hERG+minK activation V h to a similar extent than in the absence of the accessory protein (from 14 ± 4.1 to 27.7 ± 3.1 mV; n = 7 paired cells; p < 0.01). As expected, MIRP1 shifted hERG activation V h to more negative potentials. However, when PE was added to the cells the approximately 14 mV shift in I hERG+MIRP1 activation half voltage was again observed (from -1.2 ± 3 to 12.2 ± 3.6 mV; n = 13 paired cells; p < 0.01). As the effect of PE on the activation V h of I hERG+minK , I hERG+MIRP1 and I hERG is basically identical, we can conclude that minK and MIRP1 do not alter the hERG channel response to the α1-ARs stimulation (Fig. 2C) .
Intracellular pathway mediating the α1-AR modulation of hERG
The α1-adrenoceptor belongs to a G-protein coupled receptors family classically associated with Gαq dissociation, phospholipase C (PLC) activation, PIP 2 hydrolysis and PKC activation. The involvement of the Gαq protein in the PE-induced I hERG reduction was confirmed with 50 µM of the specific Gαq blocker GPant2A (RPKPQQDWFDWDWM). In the presence of this blocker PE did not shift the activation half voltage of I hERG (Fig. 3) , suggesting that αq is the relevant G protein in this pathway.
In the canonical pathway, Gαq protein-activated PLC hydrolyses PIP 2 producing the PKC activators 1,2-diacylglycerol (DAG) and inositol-1,4,5,-trisphosphate (IP 3 ). We blocked these steps with three chemical tools: neomycin and an anti-PIP 2 antibody, which block the access of PLC to PIP 2 ; and the non-hydrolysable PIP 2 analogue diC8-PIP 2 , a putative competitive inhibitor of phospholipases [25] [26] [27] [28] . The presence of each of the inhibitors prevented the PE-induced shift in I hERG activation half voltage (Fig. 3) , indicating the involvement of PLC. hERG channels are modulated by Ser/Thr kinases like PKA and PKC and by Tyrosine kinases such as Src [19, 29, 30] . Scansite database reveals 1 putative phosphorylation site for Src (Y1009) and 18 sites for PKA and/or PKC in the channel sequence. Our results showed that the effect of α1-AR stimulation on I hERG does not depend on tyrosine kinases mediated phosphorylation. In the presence of the Tyr-kinase inhibitor genistein 50 µM the activation V h moved from 10.3 ± 3.4 to 25.9 ± 3 mV after adding phenylephrine (n = 9; p<0.001). However, when PKC was inhibited by BIS-1 (10 µM) PE was not able to shift the activation half voltage of I hERG to more positive potentials (from 11.2 ± 3.1 to 11.3 ± 3 mV; n=18 paired cells, ns; Fig.  3 ). Thus, PKC has a key role in the regulation of the hERG channel after α1-AR stimulation.
To confirm that PIP 2 does not directly affect the channel modulation, HEK293 cells were cotransfected with the α1-AR plus the D-hERG mutant. This mutant has a deletion of the 883-894 amino acids in the C-terminal, the main site of interaction between PIP 2 and hERG channels [13] . Perfusion of the cells with 20 µM PE shifted the activation half voltage of I D-hERG to more depolarized potentials (from 8.2 ± 3 to 20.1 ± 3 mV; n=11 paired cells; p <0.001; Fig.  4 ), same as was observed with the wild type channel. On the contrary, addition of the nonhydrolysable analogue diC-8-PIP 2 (10 μM) or the PKC blocker BIS-1 (10 µM) prevented the effect of PE on the deletion mutant, supporting the role of PKC-dependent phosphorylation of the channel (Fig. 4C) .
In previous works the four PKA phosphorylation sites and 17 of the 18 consensus PKC phosphorylation sites in hERG were mutated to alanine and the channel modulation by the α1-AR was similar to WT channels [19, 31] . However, the T74, located in the PerArnt-Sim (PAS) domain of the channel, cannot be deleted or mutated to alanine without the loss of function of the channel, showing that this is a key residue in the channel function. Interestingly, the T74 was demonstrated to be phosphorylated by PKC [32] . So we then cotransfected HEK293 cells with the α1-AR and the NTK-hERG channel, a mutant whose 2-354 amino acids containing the PAS domain and the T74 have been removed [33] . Although both activation and deactivation kinetics are faster in NTK-hERG than in WT hERG, the activation half voltage is similar and was not regulated by PE (from 9.5 ± 4.4 to 11.3 ± 3.4 mV; n=10, ns). The absence of effect of α1-AR stimulation on the NTK-hERG activation V h is again consistent with a major role of PKC in this regulation pathway. As expected, diC8-PIP2 or BIS-1 did not affect the I NTK-hERG activation V h after PE exposure (Fig. 5 ).
α1-Adrenergic modulation of I Kr in feline cardiac myocytes
In order to test whether the results obtained in HEK-hERG cells could be extrapolated to native cardiac cells we used isolated feline ventricular cardiomyocytes. All the experiments with ventricular myocytes were performed in the presence of the β-blocker propranolol 100 nM to avoid any potential effect of PE on β-ARs. As previously observed in transfected HEK293 cells, in feline native cardiomyocytes the stimulation of the α1-AR with PE reduced the I Kr activated current and shifted the activation half voltage to more depolarized potentials (from -7.4 ± 1.1 to -1.1 ± 1.2 mV, n=10 paired cells; p < 0.01). The specific α1-AR blocker prazosin (1 µM) abolished the effect on I Kr indicating that is dependent on receptor activation (Fig. 6) . The relevance of PKC in the intracellular pathway was tested using diC-8-PIP 2 and BIS-1 and, as expected, they abolished the PE effect on I Kr . Therefore, PKC has a critical role on I Kr regulation upon α1-AR stimulation in ventricular myocytes.
Discussion
Mechanisms of I hERG reduction upon α1-AR stimulation
In this work, the activation of the α1-AR with phenylephrine reduces the I hERG amplitude as previously published [12, 13, 19, 31, 34] . The experiments performed in hERG-HEK cells not expressing α1-AR show that the shift in the activation V h to more positive potentials is the cause of I hERG reduction upon α1A-AR stimulation, because there will be fewer available channels at any physiological membrane potential. The regulatory proteins minK and MIRP1 are not relevant for the α1A-adrenergic regulation of I hERG .
Jiang et al. found for the first time a reduction on I hERG amplitude by α1A-AR stimulation; however the authors did not identify the G protein involved [11] . Although this receptor can activate Gαs protein and the cAMP/PKA pathway in cardiac myocytes [35] , the most extensively documented biochemical responses to α1-AR stimulation in the heart is Gαq protein activation of phospholipase C-mediated hydrolysis of PIP2 that produces DAG and IP3 and leads to PKC activation by these second messengers [36] [37] [38] . Our results show that the regulation of hERG current is mediated by the canonical Gαq-PLC intracellular signalling pathway. It has been proposed that the effect of PLC activation on I hERG upon α1-AR stimulation might be caused by PIP 2 depletion and loss of PIP 2 -hERG interaction [12, 13] . However, other authors suggest that the channel modulation lies on DAG production and PKC-dependent phosphorylation [19, 31] . As will be discussed below, our experiments with deletion mutants support the latter.
Implication of Protein Kinases
The most common mechanism to regulate K + channels is reversible phosphorylation [35, 39] . The Tyrosine kinase Src shifts the activation half voltage of both I Kr and I hERG [30, 40] . In our work, however, inhibition of Tyrosine kinases did not prevent the shift in the activation V h induced by α1-AR stimulation, suggesting that they are not involved in this regulatory pathway.
Although several works propose a role for PKC in the modulation of hERG channels in response to Gαq protein coupled receptors [19, 29, 32, 41] , one paper using the PKC inhibitor chelerythrine excluded PKC involvement in α1-AR modulation of hERG [12] . In that study cells were incubated extracellularly for one hour with a chelerythrine concentration barely above the IC 50 , so probably neither the incubation time nor the concentration used were enough to cause a significant blockade. We have administrated the PKC blocker bisindolylmaleimide-1 in the intracellular solution to ensure inhibition of the kinase and then found that α1-AR stimulation does not shift the activation half voltage of I hERG . Thus, PKC has a key role in the regulation of the hERG channel after α1-AR stimulation.
Thomas et al. suggested that α1-AR regulation of hERG channel was mediated by both PKA and PKC by a mechanism independent of direct channel phosphorylation [19] , since PKA inhibition prevented the effect of α1-AR stimulation on I hERG but mutation of the four PKA phosphorylation sites did not. It is currently accepted that KT5720, the PKA blocker used, can also inhibit PKC at physiological ATP concentrations [42] and therefore involvement of PKA is not sustained. That work also ruled out the direct phosphorylation of the channel by PKC because mutation of 17 out of 18 phosphorylation sites to alanine did not prevent the α1-AR effect on hERG [19] . Authors could not exclude the T74 site, located in the PAS domain, as the target for PKC-dependent phosphorylation of hERG channel after α1-AR stimulation because mutation of that residue resulted in non-functional channels. In this sense, it is currently known that PKC modulates hERG channels [29, 31, 41, 43] precisely by direct phosphorylation of the T74 site [32] . Whereas point mutation or deletion of T74 causes channel loss of activity [19, 32] , the NTK-hERG mutant lacks the full PAS domain and is functional enough to allow exploring the modulation by PKC [32, 33] . In the present work, α1-ARs stimulation does not modulate I NTK-hERG , supporting a role for direct channel phosphorylation by PKC.
PIP 2 regulates inward rectifier potassium channels [44] [45] [46] [47] [48] [49] [50] [53] and a role for PIP 2 in the regulation of I Kr /I hERG by α1-AR has been proposed [12, 13, 54] .
Negative phosphate groups of the PIP 2 head interact with positively charged amino acids of the channel proteins [45, 55] and the deletion or substitution of the 883-894 amino acids in the hERG channel C-terminal eliminates the apparent main interaction site between PIP 2 and hERG [13] . We used the D-hERG mutant (deletion of C-terminal 883-894 amino acids) in order to test whether PIP 2 might be involved in the α1-AR regulation of I hERG . D-hERG mutant responds to α1-AR stimulation and behaves like the WT despite the lack of the apparent PIP 2 interaction site. On the contrary, PKC inhibition fully abolishes α1-adrenergic modulation of D-hERG, which is again consistent with a relevant role of direct phosphorylation by PKC in this pathway.
Limitations of the study
Although PE induces a positive shift in the activation V h in both HEK cells and feline cardiac myocytes, the smaller effect of PE in feline myocytes can be explained by different factors such as a lower α1-AR expression. Feline myocytes are native cells, whereas in HEK cells the receptor was transfected and overexpressed. It might also be differences in efficiency of coupling between the components of the intracellular pathway (receptor-Gq proteins; Gq-PLC; PLC-PKC;…) or a different stoichiometry between PKC and ERG channels.
Feline I Kr is not identical to transfected I hERG . In addition to the possible differences between feline and human ERG channel, it is well accepted that hERG channel resembles most but not all the characteristics of human I Kr and that accessory subunits would be required to create the chanelosome responsible for native I Kr . However, we found that the main candidates, minK or MIRP1, do not modify the effect of Phenylephrine on hERG.
Translational perspective
Our results in native, feline, cardiomyocytes reproduce what was observed in transfected cells. Thus, α1-AR stimulation reduces the I Kr activated and tail currents by shifting the voltage-dependence of activation to more depolarized potentials in a mechanism that requires PLC and PKC activation and PKC-dependent channel phosphorylation.
One common trigger of arrhythmia in LQT2 patients seems to be emotional stress and high and unexpected noise [56] . Symptomatic patients that suffer lethal and no lethal cardiac events are related with an increase in the sympathetic tone [3, [57] [58] [59] , which means a clear relation between sympathetic nervous system and arrhythmias. In fact, auditory stimulusinduced arrhythmias are almost exclusively associated with mutations in KCNH2, the gene encoding hERG [2] . β-AR and α-AR are activated by noradrenalin, but although β-ARs are saturated by moderate sympathetic activation, α1-ARs activate in situations of sympathetic hyperactivity such as emotional or physical stress. In this sense, an anti-arrhythmic effect of α1-AR blockade has been demonstrated in an animal model of LQT2 [60] . Here, we clarified the link between sympathetic nervous system hyperactivity and I Kr reduction, one of the best characterized causes of torsades de pointes and ventricular fibrillation. 
